ASC35 Injection for Weight Management
What You Need to Know Before You Apply
What is the purpose of this trial?
This randomized, double-blind, placebo-controlled single ascending dose (SAD)/ multiple ascending dose (MAD) study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ASC35 injection
Are You a Good Fit for This Trial?
This trial is for adults who are overweight or have obesity and want to manage their weight. Participants should generally be in good health aside from their weight issues. Specific inclusion and exclusion criteria apply, but details are not provided here.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- ASC35 Injection B
- Tirzepatide
Trial Overview
The study tests different doses of a new injection called ASC35 compared to a placebo (inactive shot) and Tirzepatide, an existing medication. Injections are given under the skin, with participants randomly assigned to groups without knowing which treatment they get.
How Is the Trial Designed?
9
Treatment groups
Experimental Treatment
Active Control
SAD Dose 4
SAD Dose 3
SAD Dose 2
SAD Dose 1
MAD Cohort 4
MAD Cohort 3
MAD Cohort 2
MAD Cohort 1
MAD Cohort 0
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ascletis Pharma (China) Co., Limited
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.